Department of Obstetrics/Gynecology, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, 610041, China.
J Assist Reprod Genet. 2022 Mar;39(3):757-764. doi: 10.1007/s10815-022-02431-1. Epub 2022 Feb 15.
To evaluate the unknown genetic causes of teratozoospermia, and determine the pathogenicity of candidate variants.
A primary infertile patient and his family members were recruited in the West China Second University Hospital of Sichuan University. Whole-exome sequencing was performed to identify causative genes in a man with teratozoospermia. Immunofluorescence staining and western blotting were applied to assess the pathogenicity of the identified variant. Intracytoplasmic sperm injection (ICSI) was used to assist fertilization for the patient with teratozoospermia.
We performed whole-exome sequencing (WES) and detected a novel homozygous frameshift mutation of c.335_336del [p.E112Vfs*3] in DNAJB13 on a primary infertile male patient. Intriguingly, we identified abnormal sperm morphology in this patient, with recurrent respiratory infections and chronic cough. Furthermore, we confirmed that this mutation resulted in negative effects on DNAJB13 expression in the spermatozoa of the affected individual, causing ultrastructural defects in his sperm. Remarkably, our staining revealed that DNAJB13 was expressed in the cytoplasm of primary germ cells and in the flagella of spermatids during spermiogenesis in humans and mice. Finally, we are the first group to report a favorable prognosis using ICSI for a patient carrying this DNAJB13 mutation.
Our study revealed a novel homozygous frameshift mutation of c.335_336del [p.E112Vfs*3] in DNAJB13 involved in teratozoospermia phenotype. Our study greatly expands the spectrum of limited DNAJB13 mutations, and is expected to provide a better understanding of genetic counseling diagnoses and subsequent treatment of male infertility.
评估特发性精子畸形症的未知遗传原因,并确定候选变异的致病性。
在四川大学华西第二医院招募了一名原发性不育患者及其家庭成员。对一名特发性精子畸形症患者进行全外显子组测序,以鉴定致病基因。应用免疫荧光染色和 Western blot 评估鉴定出的变异的致病性。对特发性精子畸形症患者进行胞质内精子注射(ICSI)以辅助受精。
我们对一名原发性不育男性患者进行了全外显子组测序(WES),并在 DNAJB13 上检测到一个新的纯合移码突变 c.335_336del [p.E112Vfs*3]。有趣的是,我们在该患者中发现了异常的精子形态,伴有复发性呼吸道感染和慢性咳嗽。此外,我们证实该突变导致受影响个体精子中 DNAJB13 表达异常,引起精子超微结构缺陷。值得注意的是,我们的染色显示 DNAJB13 在人类和小鼠的生精过程中,在原始生殖细胞的细胞质和精子细胞鞭毛中表达。最后,我们是第一个报告使用 ICSI 治疗携带该 DNAJB13 突变的患者获得良好预后的研究组。
我们的研究揭示了 DNAJB13 中涉及特发性精子畸形症表型的新型纯合移码突变 c.335_336del [p.E112Vfs*3]。我们的研究极大地扩展了有限 DNAJB13 突变谱,有望为男性不育症的遗传咨询诊断和后续治疗提供更好的理解。